Abstracts must be written in English and should be structured in such a way as to include: Objectives, background, methods and results and conclusions.
All abbreviations must be defined before being used as an abbreviation in the text.
The content of the abstract is solely the responsibility of the author. The original abstract is reprinted exactly as provided. It is therefore essential that the abstract is correctly typed. Avoid errors, corrections and misspellings.
Abstracts should contain no more than 250 words (1800 characters) of text in the recommended font: Times New Roman, size 12 pt. Do NOT use a smaller font size.
If including a table in the abstract, please limit the number of words in the body of the abstract to 200. If including a diagram, please ensure that the abstract text together with the diagram do not exceed one page.
Use single spacing.
Title should be typed in UPPER CASE letters in bold and not exceed more than 100 characters. Titles with more than 100 characters will be truncated.
The author/s names and institution/s should be in upper and lower case.
Please clearly indicate the name of the presenting author, who will be considered the contact person for all correspondence connected with this abstract.
Symbols, tables, graphs or pictures cannot be submitted via the website. Abstracts containing symbols, tables, graphs or pictures must be emailed as an attachment saved as a Word document to the Congress Secretariat: klimedco@ucla.edu. Include the presenting author’s full contact details as well as the category under which your abstract should be reviewed.
No endnotes or frames are acceptable.
Abstracts sent by fax will not be processed by the Secretariat and will not be forwarded to the Scientific Committee for review.
Policy Statement
The International Academy of Cardiology requires that audiences at the Academy’s educational programs be informed of a presenter’s (moderators, speakers, faculty, authors and contributors) academic and professional affiliations, as well as other commercial relationships relevant to the content of the material that is presented.
The policy allows the listener/attendee to be fully informed in evaluating the information being presented. The situations may include, but are not limited to 1) stock options or bond holdings in a for-profit corporation or self-directed pension plan, 2) research grants, 3) employment (full or part time), 4) ownership or partnership, 5) consulting fees or other remuneration received by the presenter or his/her immediate family, including support that may be provided to attend the educational meeting, 6) nonremunerative positions of influence such as officer, board member, trustee, or public spokesperson. The disclosure will be shown as an indication (by an *) for those presenters who have stated that a relationship(s) exists relevant to the topic(s) being discussed.
Indicate any author(s) who has a possible conflict of interest (see policy statement) by an asterisk (*) next to that author(s) name in the heading of the abstract
TOPICS:
MOLECULAR CARDIOLOGY, BASIC RESEARCH
Apoptosis in vascular and cardiac remodelingOxidative stress and anti-oxidant therapy
Genetic determinants of coronary heart disease
Genetic studies in cardiomyopathy
Gene transfer and therapy
The pathogenesis of atherosclerosis
Extracellular matrix and atherosclerosis
Immunological principles in coronary artery disease
Growth control and cytokines in vascular cells
Neointimal hyperplasia and vascular injury
Pharmacologic modulation of vascular-endothelial function
DIAGNOSTIC METHODS
Biochemical markers of acute ischemiaTransesophageal echocardiography
Pharmacologic stress testing – echocardiography
Echocardiography, three-dimensional reconstruction
Nuclear cardiology – new techniques to assess cardiac perfusion, function and viability
PET – new insights into myocardial metabolism
Applications of cardiac magnetic resonance imaging
CT and coronary calcification
Percutaneous coronary angioscopy
Intravascular ultrasound imaging
Intracoronary flow, doppler measurements
CORONARY ARTERY DISEASE
The plaque and acute coronary syndromesMechanisms involved in myocardial stunning, hibernation and ischemic preconditioning
Acute myocardial infarction: thrombolysis and reperfusion
Angioplasty therapy for acute myocardial infarction
Stents: new devices/optimal application/multiple stents
Antithrombotic and antiplatelet adjunctive therapy for PTCA
Blockade of tissue proliferation after coronary interventions
Restenosis – use of ionizing radiation
Nitrates, beta blockers, calcium entry blockers and ACE inhibition for myocardial ischemia/infarction
Left ventricular remodeling after myocardial infarction
Assessment of prognosis, post acute myocardial infarction
Secondary prevention, risk stratification
Cardiac rehabilitation as secondary prevention: is it worth the effort?
Can the progress of atherosclerosis be halted?
Modification of lipoproteins and coronary disease
Hypertension, new therapeutic approaches
Diabetes mellitus, obesity, insulin and atherosclerosis
Mental stress: its effect on cardiovascular health
Primary prevention of coronary artery disease in the healthy adult
Hormone therapy in postmenopausal women: does it alter coronary risk?
Prevention in children
HEART FAILURE
Neurohumoral, immunologic and cytokine aspects of heart failureNitric oxide and nitric oxide synthase in heart failure
Myocyte and receptor abnormalities in heart failure
Natriuretic peptides, endothelin: role in heart failure
Inflammatory mediators and heart failure
Dilated cardiomyopathy: various etiologies
Ischemic cardiomyopathy
Left ventricular hypertrophy and hypertrophic cardiomyopathy
Role of the pericardium, pericarditis and restrictive cardiomyopathy
Pathophysiologic and prognostic insights in valvular heart disease
Pulmonary circulation aspects, pulmonary hypertension
Predictors and markers of heart failure outcome
Exercise physiology in heart failure
Renal aspects – diuretics
Digoxin and other new inotropic agents in heart failure
ACE inhibitors and Angiotensin-ll receptor blockers
Beta-blockers and beta-adrenergic receptors in heart failure
Calcium channel blockers and promoters in heart failure
Cardiac pacing strategies in heart failure
ARRHYTHMIAS
Arrhythmias and antiarrhythmic drug therapyAtrial flutter/fibrillation – electrophysiologic concepts and clinical aspects
Management of cardiac arrhythmias pediatric population
Heart rate variability and prognostic implications
QT prolongation/dispersion: pathophysiology and prognostic implications
Sudden death
Electrophysiologic techniques of mapping and radiofrequency ablation
Advances in internal defibrillation and implantable antiarrhythmic devices
Cardiac Pacing
CARDIAC SURGERY
Advances in congenital heart diseaseAngioplasty or surgery for multivessel coronary artery disease
New approaches to surgical revascularization: Minimally invasive surgery, TMLR
Therapeutic and physiologic issues surrounding heart valve surgery
Mechanical support left ventricular assist devices
Surgery for LV dysfunction
Cardiac transplantation
MISCELLANEOUS
Practice guidelines, cost containment
Computers in cardiology